Abstract:Objective To study the expression of special AT-rich sequence-binding protein 1(SATB1) gene and its relationship with SLC22A18 protein expression in astrocytoma.Methods Fifty-six patients with astrocytomas (12 with grade Ⅰ,13 with grade Ⅱ,15 with grade Ⅲ,and 16 with grade Ⅳ),performed surgical excision in our hospitals from September 2006 to June 2010 and from September 2003 to June 2006,were chosen in our study; another 10 brain tissues from patients performed decompression operation resulting from cerebral hernia were selected as the controls.RT-PCR and Western blotting were used to detect the mRNA and protein expressions of SATB1.The SLC22A18 protein expression was detected by immunohistochemical assay.The relations between SLC22A18expressions and SA TB1 levels,and these two and the degree of malignancy were analyzed.Results RT-PCR and Western blotting revealed that positive mRNA and protein expressions were noted in 35patients with astrocytomas; the mRNA and protein expression rate and value of SATB1 in the astrocytoma tissues were significantly different among different grades of tumors (P＜0.05); the higher the malignancy grade,the higher mRNA and protein expression rate and value ofSA TB1; the protein expression value of SA TB1 had a positive correlation with the malignancy grade of tumors (r=0.987,P=0.000).And a few expressions of SA TB1 mRNA and protein were found in the tissues of controls.Immunohistochemical assay indicated that positive protein expression of SLC22A18 was noted in 19 astrocytoma tissues,and the protein expression rate of SLC22A18 in the astrocytoma tissues was significantly different among different grades of tumors (P＜0.05); the higher the malignancy grade,the lower expression of SLC22A18.And the protein expression of SLC22A18 was found in all the tissues of controls.The SATB1 expression rate in the tissues with negative SLC22A18 expression (81.1％) was significantly higher than that in the tissues with positive SLC22A18 expression (26.3％,P＜0.05).Conclusion SATB1 expresses in the astrocytoma tissues,indicating that it may play an important role in the pathogenesis of astrocytoma;up-regulation of SATB1 expression and dysfunction of SLC22A18 may play synergetic roles in the process of carcinogenesis of astrocytoma.

Expression of SATB1 in breast cancer and its relationship with clinicopathological features

Special AT-rich Sequence-Binding Protein 1 Promotes Cell Growth and Metastasis in Colorectal Cancer.

SATB1 is Correlated with Progression and Metastasis of Breast Cancers: A Meta-Analysis.

Expression of Special AT-rich Sequence-Binding Protein and Its Clinicopathological Significance in Epithelial Ovarian Cancer

Satb1 Expression Is Associated With Biologic Behavior In Colorectal Carcinoma In Vitro And In Vivo

Overexpression of SATB1 in laryngeal squamous cell carcinoma.

SATB1 is an Independent Prognostic Marker for Gastric Cancer in a Chinese Population

Special AT-rich DNA-binding Protein-1 Expression is Associated with Liver Cancer Metastasis

Expression of Special AT-rich Sequence Binding Protein-1 in Thyroid Cancer and Effect of Special AT-rich Sequence Binding Protein-1 on the Invasion of Thyroid Cancer Cells

At-Rich Sequence Binding Protein 1: Contribution to Tumor Progression and Metastasis of Human Ovarian Carcinoma

Expression of SATB1 and its clinicopathologic significance in colorectal cancer

SATB2 expression and its relationship with clinicopathological features in primary colorectal cancer tissues and metastatic lymph nodes

Expression of Special AT-rich Sequence-Binding Protein (SATB1) in Clear Cell Renal Carcinoma

Expression of SATB1 Promotes the Growth and Metastasis of Colorectal Cancer

Correlation of SATB1 Overexpression with the Progression of Human Rectal Cancer

SATB1 promotes prostate cancer metastasis by the regulation of epithelial–mesenchymal transition

Upregulation of SATB1 is Associated with the Development and Progression of Glioma

Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features.

LncRNA SATB2-AS1 Promotes Tumor Growth and Metastasis and Affects the Tumor Immune Microenvironment in Osteosarcoma by Regulating SATB2

Expression of Special AT-rich Sequence-Binding Protein 1 Gene and Its Relationship with SLC22A18 Protein Expression in Astrocytoma

Decreased SATB 2 Expression is Associated with Metastasis and Poor Prognosis in Human Clear Cell Renal Cell Carcinoma